In the past week, CARE stock has gone up by 4.46%, with a monthly gain of 10.07% and a quarterly surge of 13.07%. The volatility ratio for the week is 2.59%, and the volatility levels for the last 30 days are 2.29% for Carter Bankshares Inc The simple moving average for the past 20 days is 7.64% for CARE’s stock, with a 6.31% simple moving average for the past 200 days.
Is It Worth Investing in Carter Bankshares Inc (NASDAQ: CARE) Right Now?
Carter Bankshares Inc (NASDAQ: CARE) has a higher price-to-earnings ratio of 15.23x compared to its average ratio. CARE has 36-month beta value of 0.82. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy”, 1 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for CARE is 22.25M, and currently, short sellers hold a 3.17% ratio of that float. The average trading volume of CARE on July 04, 2025 was 87.73K shares.
CARE stock’s latest price update
Carter Bankshares Inc (NASDAQ: CARE)’s stock price has increased by 2.07% compared to its previous closing price of $17.88. However, the company has seen a 4.46% increase in its stock price over the last five trading sessions. businesswire.com reported 2025-06-25 that ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) company and a leader in clinical genomic testing, announced today that a peer-reviewed study validating the accuracy of the Ambry CARE Program® (CARE) for hereditary cancer risk assessment has been published in the Journal of the National Comprehensive Cancer Network. The study, “Validation of a Digital Tool that Uses National Testing Guidelines to Identify Individuals at Risk fo.
Analysts’ Opinion of CARE
Many brokerage firms have already submitted their reports for CARE stocks, with Hovde Group repeating the rating for CARE by listing it as a “Outperform”. The predicted price for CARE in the upcoming period, according to Hovde Group is $22 based on the research report published on October 02, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see CARE reach a price target of $17. The rating they have provided for CARE stocks is “Outperform” according to the report published on May 01st, 2023.
Piper Sandler gave a rating of “Neutral” to CARE, setting the target price at $19 in the report published on December 05th of the previous year.
CARE Trading at 12.13% from the 50-Day Moving Average
After a stumble in the market that brought CARE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.54% of loss for the given period.
Volatility was left at 2.29%, however, over the last 30 days, the volatility rate increased by 2.59%, as shares surge +10.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.52% upper at present.
During the last 5 trading sessions, CARE rose by +4.46%, which changed the moving average for the period of 200-days by +4.82% in comparison to the 20-day moving average, which settled at $16.95. In addition, Carter Bankshares Inc saw 22.40% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CARE starting from Bloomfield Kevin S., who sold 1,629 shares at the price of $16.81 back on Jun 12 ’25. After this action, Bloomfield Kevin S. now owns 16,418 shares of Carter Bankshares Inc, valued at $27,377 using the latest closing price.
Bloomfield Kevin S., the Director of Carter Bankshares Inc, sale 4,509 shares at $16.71 during a trade that took place back on Jun 11 ’25, which means that Bloomfield Kevin S. is holding 18,047 shares at $75,367 based on the most recent closing price.
Stock Fundamentals for CARE
Current profitability levels for the company are sitting at:
- 0.14% for the present operating margin
- 0.59% for the gross margin
The net margin for Carter Bankshares Inc stands at 0.11%. The total capital return value is set at 0.07%. Equity return is now at value 7.20%, with 0.59% for asset returns.
Based on Carter Bankshares Inc (CARE), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 0.47. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is 0.32.
Currently, EBITDA for the company is 37.92 million with net debt to EBITDA at -0.81. When we switch over and look at the enterprise to sales, we see a ratio of 1.6. The receivables turnover for the company is 3.81for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.03.
Conclusion
To put it simply, Carter Bankshares Inc (CARE) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
